Table 4 Clinical management in the previous 12 months
| Â | Diabetes | CHF |
|---|---|---|
Mean number of contacts | Â | Â |
Disease specific consultation | 10,17 | 3,71 |
Blood value monitoring | 4,44 | 3,14 |
Monitoring in % (N) | Â | Â |
Weight | 94 (17/18) | 43 (3/7) |
Body Mass Index | 83 (15/18) | 29 (2/7) |
Systolic blood pressure | 100 (18/18) | 86 (6/7) |
HbA1C | 83 (15/18) | - |
Glucose | 78 (14/18) | 57 (4/7) |
Creatinine | 44 (8/18) | 86 (6/7) |
Potassium | 39 (7/18) | 71 (5/7) |
Sodium | 22 (4/18) | 71 (5/7) |
Total cholesterol | 50 (9/18) | 57 (4/7) |
HDL | 50 (9/18) | 57 (4/7) |
LDL | 44 (8/18) | 57 (4/7) |
Triglycerides | 61 (11/18) | 57 (4/7) |
Treatment in % (N) | Â | Â |
No treatment | 11 (2/18) | - |
Diet | 28 (5/18) | - |
Oral medication | 67 (12/18) | - |
Insulin | 22 (4/18) | - |
Antihypertensive | 89 (16/18) | 100 (7/7) |
Lipid-lowering medication | 78 (14/18) | 57 (4/7) |
ACE-inhibitor | - | 57 (4/7) |
Beta blocker | - | 86 (6/7) |
Furosemide + ACE-inhibitor in comb. w/NSAID | - | 43 (3/7) |